Mark Harber

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

Paul Griffiths, Anna Stanton, Erin McCarrell et al. · The Lancet · 2011 · 390 citations · Full text

Vaccination, Mf59 Adjuvant, Transplantation +10

Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy

Sowsan Atabani, Colette Smith, Claire Atkinson et al. · American Journal of Transplantation · 2012 · 209 citations · Full text

The European Green Deal and nephrology: a call for action by the European Kidney Health Alliance

Raymond Vanholder, John Agar, Marion Braks et al. · Nephrology Dialysis Transplantation · 2022 · 80 citations · Full text

Engineering, Environmental Impact Assessment, European Green Deal +21

Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids

Gareth Jones, Maciej Juszczak, Edward Kingdon et al. · Nephrology Dialysis Transplantation · 2004 · 61 citations · Full text

Major histocompatibility complex class I–related chain A allele mismatching, antibodies, and rejection in renal transplantation

S.T. Cox, Henry A. F. Stephens, Raymond Fernando et al. · Human Immunology · 2011 · 59 citations

Transplant Rejection, Histocompatibility, Urology +11